Firma Clinical Research promoted Jennifer Mintz to Chief Commercial Officer to oversee business development, marketing, contracts and proposals.
| CHICAGO, Jan. 18, 2022 /PRNewswire/ -- Firma Clinical Research , a niche service provider to contract research organizations, promoted Jennifer Mintz to Chief Commercial Officer to oversee business development, marketing, contracts and proposals.
Firma Clinical Research Promotes Jennifer Mintz to Chief Commercial Officer In her new role, Mintz will continue to work closely with Firma’s CEO, Michael Woods and all the departments to achieve the company’s goals. Mintz joined Firma in 2018 as Executive Director and was named Vice President of Sales and Marketing in 2019. Mintz has experience leading sales teams in eClinical Technology, CROs (contract research organizations), decentralized clinical trials and patient recruitment. Prior to joining Firma, she held sales management positions with companies such as Acurian, Worldwide Clinical Trials, and BioClinica. “Jen is dedicated to Firma’s success in both data services and home trial services, and this promotion acknowledges her integral leadership in advancing the Firma brand,” says Michael Woods, CEO, Firma Clinical Research. “Having Jen oversee business development, marketing and contracts and proposals will benefit Firma’s team, customers and partners and help us continue to support successful clinical trials, including decentralized trials.” Mintz holds a master’s degree and bachelor’s degree from Johnson & Wales University in Providence, Rhode Island. About Firma Clinical Research
SOURCE Firma Clinical Research |
View original content to download multimedia:
